Phase 2 Maximum Tolerated Dose determined in Phase 1

5 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Phase 2 Maximum Tolerated Dose determined in Phase 1
Treatment and conditionWhere it standsTrials
Phase 2 Maximum Tolerated Dose determined in Phase 1 for anemia, refractory, with excess of blastsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Phase 2 Maximum Tolerated Dose determined in Phase 1 for congenital bone marrow failure syndromesPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Phase 2 Maximum Tolerated Dose determined in Phase 1 for hemoglobinopathiesPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Phase 2 Maximum Tolerated Dose determined in Phase 1 for immunologic deficiency syndromesPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Phase 2 Maximum Tolerated Dose determined in Phase 1 for metabolism, inborn errorsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1